I35.0 I50.1
Conditions
Interventions
Group 1: A retrospective data analysis of all patients with native severe aortic stenosis who underwent transfemoral transcatheter aortic valve implantation (TF-TAVI) from January 2006 to July 2016 in
Sponsors
Universitätsklinikum EssenWestdeutesches Herz- und Gefäßzentrum, EssenKlinik für Kardiologie und Angiologie
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: All patients with native severe aortic stenosis (AS) who underwent transfemoral transcatheter aortic valve implantation (TF-TAVI) in West German Heart and Vascular Center, Essen, from January 2006 to July 2016.
Exclusion criteria
Exclusion criteria: (1) Severe aortic regurgitation, degenerated aortic bioprosthesis or bicuspid aortic valve as a primary indication for transfemoral transcatheter aortic valve implantation (TF-TAVI), (2) Baseline transthoracic echocardiography not performed in our center, (3) TF-TAVI abrted/not performed
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| All-cause mortality at 30-day and 1-year follow-up. Mortality status (yes/no) and date were obtained from medical records, telephone contact with patients, next kin or their family physicians. Patients were censored at time of death or completion of 1-year follow-up, whichever occurred first. | — |
Secondary
| Measure | Time frame |
|---|---|
| Interaction between the impact of baseline left ventricular ejection fraction (LVEF) and low gradient aortic stenosis (LGAS) on 30-day and 1-year mortality after TF-TAVI. This interaction will be assessed with Kaplan Meier method and Cox regression analysis. | — |
Countries
Germany
Contacts
Public ContactPhilipp Kahlert
Universitätsklinikum EssenWestdeutesches Herz- und Gefäßzentrum, EssenKlinik für Kardiologie und Angiologie
Outcome results
None listed